Comparative Efficacy of Typical and Atypical Antipsychotics as Add-On Therapy to Mood Stabilizers in the Treatment of Acute Mania
The DOI matches its Crossref record.
Abstract
BACKGROUND: Typical antipsychotics are commonly used in combination with mood stabilizers for acute mania. Although typical antipsychotics are effective, they have undesirable side effects such as induction of depressive symptoms and tardive dyskinesia. Atypical antipsychotics have more favorable side effect profiles, and recent evidence shows their efficacy in treating mania. Apart from a previous small study that compared risperidone with typical neuroleptics as add-on therapy to mood stabilizers, no studies to date have directly compared atypical antipsychotics with typical antipsychotics as add-on therapy to mood stabilizers in a clinically relevant, naturalistic setting. METHOD: This study is a chart review of all patients with DSM-IV-defined bipolar disorder, current episode mania (N = 204), admitted to the University of British Columbia Hospital during a 30-month period. Patients were separated into 3 groups according to the medications used: (1) mood stabilizer and typical antipsychotic, (2) mood stabilizer and atypical antipsychotic, and (3) combination: mood stabilizer plus a typical antipsychotic, then switched to mood stabilizer plus risperidone or olanzapine within I week. The atypical group was further subdivided into risperidone and olanzapine subgroups. Outcome was measured using Clinical Global Impressions-Severity of Illness (CGI-S) and -Improvement (CGI-I) ratings generated by review of clinical information in the chart. RESULTS: Patients treated with typical antipsychotics were more severely ill at admission and at discharge than those treated with atypical antipsychotics. Patients in the atypical (p < .005) and combination (p < .05) groups showed significantly greater clinical improvement at discharge than patients treated with typical antipsychotics. This difference was also significant in the subset of patients with psychotic features (p < .03). Risperidone and olanzapine were associated with fewer extrapyramidal side effects than were typical antipsychotics (risperidone vs. typical antipsychotics, chi2 = 8.72, p < .01; olanzapine vs. typical antipsychotics, chi2 = 16.9, p < .001). CONCLUSION: Due to their superior effectiveness and side effect profile when compared with typical antipsychotics. atypical antipsychotics are an excellent choice as add-on therapy to mood stabilizers for the treatment of patients with mania.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While conventional antipsychotics such as haloperidol are often associated with EPS (including pseudoparkinsonism, akathisia, acute dystonia, and tardive dyskinesia),861 this risk is either absent or low with atypical antipsychotic agents.862, 863”
Citations
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationYatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., Sharma, V., Silverstone, P., Alda, M., Baruch, P., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00219.x · Cited by 388
“Conventional antipsychotics, particularly the high potency drugs, are often associated with EPS (698), but atypical antipsychotics have a much lower rate of EPS comparable in most studies to that seen with placebo (533, 699).”
ResultSelf-citationSmulevich, A. B., Khanna, S., Eerdekens, M., Karcher, K., Kramer, M., & Grossman, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.003 · Cited by 192
“The lower incidence of EPS with risperidone demonstrated here is consistent with the well-recognized lower liability for EPS associated with atypical than conventional antipsychotics (Lemmens et al., 1999; Miller et al., 2001; Owens, 1994).”
ResultRisperidone in the treatment of acute mania: Double-blind, placebo-controlled study
Khanna, S., Vieta, E., Lyons, B., Grossman, F., Eerdekens, M., & Kramer, M. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.3.229 · Cited by 188
“…(Segal et al, 1998; Tohen et al, 1999; Vieta et al, 2004) or in combination with mood stabilisers (Ghaemi et al, 1997; Suppes et al, 1999; Miller et al, 2001; Vieta et al, 2001; Sachs et al, 2002, 2004; Tohen et al, 2002; Yatham et al, 2003), have been shown to be effective and well…”
BackgroundAnnual cost of bipolar disorder to UK society
Das Gupta, R., & Guest, J. F. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.3.227 · Cited by 184
Metadata
- Authors
- Miller, D. S., Yatham, L. N., & Lam, R. W.
- Affiliations
- University of British Columbia (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-12-15
- Volume
- 62
- Issue
- 12
- Pages
- 975-980
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2057639493
- Cited by
- 103
- References
- 0
- Citations by year
- 2026: 1 · 2022: 1 · 2020: 27 · 2019: 1 · 2018: 1 · 2016: 28 · 2015: 2 · 2013: 1 · 2012: 5
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- acute mania, bipolar disorder, atypical antipsychotics, typical antipsychotics, mood stabilizers, adjunctive therapy, risperidone, olanzapine, extrapyramidal symptoms, tardive dyskinesia, depressive symptoms, psychotic features, clinical improvement, hospital admission outcomes, antipsychotic adverse effects, naturalistic settings
- MeSH terms
- Olanzapine, Acute Disease, Adult, Basal Ganglia Diseases, Benzodiazepines, Bipolar Disorder, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Length of Stay, Male, Middle Aged, Neurologic Examination, Pirenzepine, Psychiatric Status Rating Scales, Retrospective Studies, Antipsychotic Agents, Treatment Outcome, Antimanic Agents, Risperidone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative Efficacy of Typical and Atypical Antipsychotics as Add-On Therapy to Mood Stabilizers in the Treatment of Acute Mania. https://app.cochat.ai/papers/10.4088/jcp.v62n1210
- The paper
- Miller, D. S., Yatham, L. N., & Lam, R. W. (2001). Comparative Efficacy of Typical and Atypical Antipsychotics as Add-On Therapy to Mood Stabilizers in the Treatment of Acute Mania. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v62n1210
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.